DE69322750D1 - Dibekacin und Arbekacin Derivate wirksam gegen resistente Bakterien, und ihre Herstellung - Google Patents

Dibekacin und Arbekacin Derivate wirksam gegen resistente Bakterien, und ihre Herstellung

Info

Publication number
DE69322750D1
DE69322750D1 DE69322750T DE69322750T DE69322750D1 DE 69322750 D1 DE69322750 D1 DE 69322750D1 DE 69322750 T DE69322750 T DE 69322750T DE 69322750 T DE69322750 T DE 69322750T DE 69322750 D1 DE69322750 D1 DE 69322750D1
Authority
DE
Germany
Prior art keywords
dibekacin
manufacture
effective against
resistant bacteria
against resistant
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69322750T
Other languages
English (en)
Other versions
DE69322750T2 (de
Inventor
Shinichi Kondo
Seiji Shibahara
Takayuki Usui
Toshiaki Kudo
Shuichi Gomi
Atsushi Tamura
Yoko Ikeda
Daishiro Ikeda
Tomio Takeuchi
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Microbial Chemistry Research Foundation
Original Assignee
Microbial Chemistry Research Foundation
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from JP34131492A external-priority patent/JP3215732B2/ja
Priority claimed from JP24732793A external-priority patent/JP3215759B2/ja
Application filed by Microbial Chemistry Research Foundation filed Critical Microbial Chemistry Research Foundation
Application granted granted Critical
Publication of DE69322750D1 publication Critical patent/DE69322750D1/de
Publication of DE69322750T2 publication Critical patent/DE69322750T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H15/00Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
    • C07H15/20Carbocyclic rings
    • C07H15/22Cyclohexane rings, substituted by nitrogen atoms
    • C07H15/222Cyclohexane rings substituted by at least two nitrogen atoms
    • C07H15/226Cyclohexane rings substituted by at least two nitrogen atoms with at least two saccharide radicals directly attached to the cyclohexane rings
    • C07H15/234Cyclohexane rings substituted by at least two nitrogen atoms with at least two saccharide radicals directly attached to the cyclohexane rings attached to non-adjacent ring carbon atoms of the cyclohexane rings, e.g. kanamycins, tobramycin, nebramycin, gentamicin A2

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
DE69322750T 1992-11-27 1993-11-26 Dibekacin und Arbekacin Derivate wirksam gegen resistente Bakterien, und ihre Herstellung Expired - Fee Related DE69322750T2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP34131492A JP3215732B2 (ja) 1992-11-27 1992-11-27 耐性菌に有効なジベカシン誘導体またはアルベカシン誘導体とそれらの製造法
JP24732793A JP3215759B2 (ja) 1993-09-09 1993-09-09 耐性菌に有効な5−置換−2″−アミノ−2″−デオキシアルベカシンとその製造法

Publications (2)

Publication Number Publication Date
DE69322750D1 true DE69322750D1 (de) 1999-02-04
DE69322750T2 DE69322750T2 (de) 1999-08-19

Family

ID=26538214

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69322750T Expired - Fee Related DE69322750T2 (de) 1992-11-27 1993-11-26 Dibekacin und Arbekacin Derivate wirksam gegen resistente Bakterien, und ihre Herstellung

Country Status (4)

Country Link
US (2) US5488038A (de)
EP (1) EP0601909B1 (de)
DE (1) DE69322750T2 (de)
ES (1) ES2128404T3 (de)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20040058880A1 (en) * 2002-07-01 2004-03-25 Chang-Hsing Liang Aminoglycoside antibiotics as novel anti-infective agents
WO2005070945A1 (ja) * 2004-01-21 2005-08-04 Meiji Seika Kaisha, Ltd. メチシリン耐性黄色ブドウ球菌(mrsa)に有効な新規アミノグリコシド系抗生物質
US7794713B2 (en) * 2004-04-07 2010-09-14 Lpath, Inc. Compositions and methods for the treatment and prevention of hyperproliferative diseases
PT2316419E (pt) 2004-05-17 2012-10-22 Gilead Sciences Inc Combinação de fosfomicina/aminoglicósido em aerossol para o tratamento de infeções respiratórias bacterianas
GB0411948D0 (en) * 2004-05-28 2004-06-30 Univ Leeds Compounds
JP5034946B2 (ja) * 2005-08-29 2012-09-26 味の素株式会社 栄養組成物
US20080213274A1 (en) * 2005-10-28 2008-09-04 Sabbadini Roger A Compositions and methods for the treatment and prevention of fibrotic, inflammatory, and neovascularization conditions of the eye
US20090074720A1 (en) * 2005-10-28 2009-03-19 Sabbadini Roger A Methods for decreasing immune response and treating immune conditions
US7862812B2 (en) * 2006-05-31 2011-01-04 Lpath, Inc. Methods for decreasing immune response and treating immune conditions
AU2009299118B2 (en) 2008-10-03 2015-12-17 Glycan Biosciences Llc Anionic conjugates of glycosylated bacterial metabolite
AU2011211744B2 (en) * 2010-02-03 2015-06-18 Microbial Chemistry Research Foundation Read through inducer, and therapeutic agent for nonsense-mutation-type genetic diseases
CN116462721B (zh) * 2023-04-18 2024-02-02 江南大学 抗菌性氨基糖苷衍生物

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4001208A (en) 1972-10-06 1977-01-04 Zaidan Hojin Biseibutsu Kagaku Kenkyo Kai 1-N-[(S)-α-hydroxy-ω-aminoacyl]
US4107424A (en) * 1972-10-06 1978-08-15 Zaidan Hojin Biseibutsu Kagaku Kenkyu Kai 1-N-[(S)-α-hydroxy-ω-aminoacyl] derivatives of 3',4'-dideoxykanamycin B and 3'-deoxykanamycin B antibiotics
US3974198A (en) 1975-09-02 1976-08-10 General Electric Company Process for producing methyltriacetoxysilane
JPS6029720B2 (ja) * 1975-12-11 1985-07-12 財団法人微生物化学研究会 3′,4′‐ジデオキシカナマイシンbの新規な製造法
US4187372A (en) * 1976-09-08 1980-02-05 Abbott Laboratories Seldomycin factor 5 derivative
IE48972B1 (en) 1978-11-11 1985-06-26 Microbial Chem Res Found The production of a selectively protected n-acylated derivative of an aminoglycosidic antibiotic
JPS631319A (ja) 1986-06-18 1988-01-06 多摩川精機株式会社 Ac機器動作検出回路
JPS6339891A (ja) * 1986-08-04 1988-02-20 Microbial Chem Res Found 5−デオキシ−5−フルオロカナマイシンb誘導体とその製造法
JPH0764866B2 (ja) * 1987-02-24 1995-07-12 財団法人微生物化学研究会 1−n−(4−アミノ−3−フルオロ−2−ヒドロキシブチリル)カナマイシン類

Also Published As

Publication number Publication date
EP0601909A3 (en) 1997-03-19
EP0601909B1 (de) 1998-12-23
ES2128404T3 (es) 1999-05-16
DE69322750T2 (de) 1999-08-19
US5488038A (en) 1996-01-30
EP0601909A2 (de) 1994-06-15
US5618795A (en) 1997-04-08

Similar Documents

Publication Publication Date Title
ATE258549T1 (de) Oxazolidindion-derivate, ihre herstellung und verwendung
DE69604653T2 (de) Taxol derivate, deren herstellung und diese enthaltende pharmazeutischen zusammenstellungen
EE200000468A (et) Ühendid, nende kasutamine ja farmatseutiline kompositsioon
DE69427970D1 (de) Medikament gegen atopische krankheiten
DE69630145D1 (de) Taxal derivate, deren herstellung und diese enthaltende pharmazeutische zusammenstellungen
DE69516198T2 (de) Textil-Strukturen und ihre Herstellung
DE59905572D1 (de) Substituierte 4-amino-2-aryl-pyrimidine, ihre herstellung, ihre verwendung und sie enthaltende pharmazeutische präparate
DE69322750D1 (de) Dibekacin und Arbekacin Derivate wirksam gegen resistente Bakterien, und ihre Herstellung
DE59208576D1 (de) 3-Isoxazolylphenylverbindungen, ihre Herstellung und ihre Verwendung
DE69608680T2 (de) Taxal derivate, deren herstellung und diese enthaltende pharmazeutische zusammenstellungen
FI956298A0 (fi) 3-fenyyli-isokinolin-1(2H)-oneja, niiden valmistus ja terapeuttinen käyttö
DE59409541D1 (de) Bicyclen-derivate, ihre herstellung und verwendung
DE60005690D1 (de) Titanverbindungen, deren herstellung und verwendung
DE69317265D1 (de) Konstruktionselement und dessen herstellung
DE69420095D1 (de) Derivate von Polysacchariden, ihre Herstellung und Verwendung
DE69706146T2 (de) Taxoide, ihre herstellung und diese enthaltende pharmazeutische zusammensetzungen
DE69514398T2 (de) 13-Substituierte Milbemycinderivate, ihre Herstellung und Verwendung
DE69604071T2 (de) Oxazolidinone derivate, ihre herstellung und ihre therapeutische verwendung
FI953956A0 (fi) 2,3-rengaskondensoidut 1,4-dihydropyridiinit, menetelmät niiden valmistamiseksi ja niiden käyttö lääkkeinä
DE69327813D1 (de) Alpha-Glucosyl-Catecholaminderivate, ihre Salze, Herstellung und Verwendung
DE69611758D1 (de) N-1-carbocylalkyl derivate von lsd
DE59501950D1 (de) Isolongifolanol-Derivate, ihre Herstellung und ihre Verwendung
ATE198192T1 (de) Benzolsulfonamidderivate, ihre herstellung und ihre therapeutische verwendung
ATE197448T1 (de) Neue carbonsäurederivate, ihre herstellung und verwendung
ITRM920305A1 (it) Composizione farmaceutica per il trattamento dello shock, particolarmente dello shock cardiogeno e dello shock settico.

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee